返回ChemicalBook首页>CAS数据库列表>6804-07-5

6804-07-5

中文名称 卡巴多
英文名称 Carbadox
CAS 6804-07-5
分子式 C11H10N4O4
分子量 262.22
MOL 文件 6804-07-5.mol
更新日期 2024/04/18 11:50:11
6804-07-5 结构式 6804-07-5 结构式

基本信息

中文别名
痢立清
喹肼脂
卡巴得
卡巴氧
卡巴多
卡巴多司
2(2-喹啉基-1,1-亚甲基)肼基甲酸甲酯
N,N’-二氧化甲基(2-喹喔啉基亚甲基)肼羧酸酯
2-(喹喔啉-2-亚甲基)肼-羧酸甲酯-N,N'-二氧化物
英文别名
CBX
M31
MOD1
gs6244
Mecadox
CARBADO
p25beta
getroxel
fortigro
karbadox
所属类别
分析化学:生命科学标准品

物理化学性质

熔点239-240°C
沸点405.47°C (rough estimate)
密度1.3602 (rough estimate)
折射率1.6000 (estimate)
闪点18°(64°F)
储存条件2-8°C
溶解度DMSO(轻微超声处理)
酸度系数(pKa)10.51±0.46(Predicted)
形态粉末
颜色黄色至深黄色
水溶解性Soluble in 1N NaOH (50 mg/ml), and water (partly).
稳定性感光
CAS 数据库6804-07-5

安全数据

危险性符号(GHS)
GHS02,GHS07,GHS08
警示词危险
危险性描述H228-H302-H350
危险品标志F,T
危险类别码45-11-22
安全说明53-45
危险品运输编号UN 1325 4.1/PG 2
WGK Germany3
RTECS号FE2779000
危险等级4.1
海关编码29339900

应用领域

用途1
用作药用辅料、饲料添加剂
卡巴多价格(试剂级)
报价日期产品编号产品名称CAS号包装价格
2024/01/25HY-B1340卡巴多
Carbadox
6804-07-5100mg400元
2024/01/25HY-B1340卡巴多
Carbadox
6804-07-510mM * 1mLin DMSO440元

常见问题列表

生物活性
Carbadox 是一种喹喔啉二氧化氮抗生素化合物,广泛用于育龄期的猪,以控制肠道疾病,提高饲料利用率。
靶点

Bacterial

体外研究

The results of MTT assay demonstrate a dose-dependent decrease in mitochondrial activity in Vero cells at all concentrations of Carbadox. Treatment with Carbadox at the highest concentration of 160 μg/mL results in cell viability down to only 12%. Cells following Carbadox treatment show a dose-dependent increase of the DNA migration (p<0.01). The nuclear division index (NDI) reduces markedly with the increase doses of Carbadox.

体内研究

Alpha diversities (Shannon diversity, Heips evenness, and inverse Simpson indices) of samples from medicated piglets compare to non-medicated piglets are significantly different at 2, 3, and 4 days after continuous Carbadox, but not different in either late Carbadox or at any time during the withdrawal period. Analysis of the community structure of bacteria in animals shows significant differences at days 3 and 4 of early Carbadox treatment ([R=0.32, p=0.015] and [R=0.54, p=0.003], respectively), but not before starting antibiotic treatment (p=0.82). No significant differences in E. coli colony forming units (CFUs) are observed during the Carbadox-treatment period of the study or late in the withdrawal period. E. coli CFUs are significantly different between the medicated and non-medicated groups on day 2 after the withdrawal of Carbadox.

"6804-07-5" 相关产品信息
99-75-2 80-62-6 671-16-9 99-76-3 2417-72-3 96-33-3 302-01-2 91-19-0 107-31-3 6294-89-9 60-34-4 74-83-9